Medicinal properties of mangiferin, structural features, derivative synthesis, pharmacokinetics and biological activities

Mini-Reviews in Medicinal Chemistry

Volumn 15, Issue 7, 2015, Pages 582-594

  Benard, Outhiriaradjou ^a   Chi, Yuling ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

Mangiferin; Metabolic disorders; Metabolism; Pharmacokinetics; Structure activity relationship

Indexed keywords

ADVANCED GLYCATION END PRODUCT; GELATINASE B; MANGIFERIN; MATRILYSIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PYRUVATE DEHYDROGENASE KINASE 4; STEROL REGULATORY ELEMENT BINDING PROTEIN; XANTHONE DERIVATIVE;

ANTIINFLAMMATORY ACTIVITY; ANTINEOPLASTIC ACTIVITY; ARTICLE; BIOENERGY; BIOLOGICAL ACTIVITY; CARDIOVASCULAR DISEASE; CHEMICAL REACTION; DERIVATIZATION; DOWN REGULATION; DRUG METABOLISM; DRUG SYNTHESIS; ENERGY METABOLISM; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HYPERGLYCEMIA; HYPERLIPIDEMIA; IMMUNE RESPONSE; INSULIN SENSITIVITY; LIPID PEROXIDATION; LIPOGENESIS; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PROTEIN EXPRESSION; STRUCTURE ACTIVITY RELATION; THIN LAYER CHROMATOGRAPHY; TOXICITY TESTING; UPREGULATION; ANIMAL; CHEMICAL STRUCTURE; CHEMISTRY; GENE EXPRESSION REGULATION; PHYSIOLOGY;

ANIMALS; GENE EXPRESSION REGULATION; HUMANS; MOLECULAR STRUCTURE; STRUCTURE-ACTIVITY RELATIONSHIP; XANTHONES;

EID: 84929336596     PISSN: 13895575     EISSN: 18755607     Source Type: Journal    
DOI: 10.2174/1389557515666150401111410     Document Type: Article

References (137)

1. Newman, D. J.; Cragg, G. M., Natural products as sources of new drugs over the last 25 years. J. Nat. Prod., 2007, 70 (3), 461- 477.
2. Butler, M. S., Natural products to drugs: natural product derived compounds in clinical trials. Nat. Prod. Rep., 2005, 22 (2), 162-195.
3. Vyas, A.; Syeda, K.; Ahmad, A.; Padhye, S.; Sarkar, F. H., Perspectives on Medicinal properties of Mangiferin. Mini Rev. Med. Chem., 2012, 12(5), 412-425.
4. Andreu, G. P.; Delgado, R.; Velho, J.; Inada, N. M.; Curti, C.; Vercesi, A. E., Mangifera indica L. extract (Vimang) inhibits Fe2+- citrate-induced lipoperoxidation in isolated rat liver mitochondria. Pharmacol. Res., 2005, 51 (5), 427-435.
5. Andreu, G. P.; Delgado, R.; Velho, J. A.; Curti, C.; Vercesi, A. E., Iron complexing activity of mangiferin, a naturally occurring glucosylxanthone, inhibits mitochondrial lipid peroxidation induced by Fe2+-citrate. Eur. J. pharmacol., 2005, 513 (1-2), 47- 55.
6. Leiro, J. M.; Alvarez, E.; Arranz, J. A.; Siso, I. G.; Orallo, F., In vitro effects of mangiferin on superoxide concentrations and expression of the inducible nitric oxide synthase, tumour necrosis factor-alpha and transforming growth factor-beta genes. Biochem. Pharmacol., 2003, 65 (8), 1361-1371.
7. Andreu, G. L. P.; Delgado, R.; Velho, J. A.; Curti, C.; Vercesi, A. E., Mangiferin, a natural occurring glucosyl xanthone, increases susceptibility of rat liver mitochondria to calcium-induced permeability transition. Arch. Biochem. Biophy., 2005, 439 (2), 184- 193.
8. Leiro, J.; Arranz, J. A.; Yanez, M.; Ubeira, F. M.; Sanmartin, M. L.; Orallo, F., Expression profiles of genes involved in the mouse nuclear factor-kappa B signal transduction pathway are modulated by mangiferin. Intl. Immunopharmacol., 2004, 4 (6), 763-78.
9. Muruganandan, S.; Srinivasan, K.; Gupta, S.; Gupta, P. K.; Lal, J., Effect of mangiferin on hyperglycemia and atherogenicity in streptozotocin diabetic rats. J. ethnopharmacol., 2005, 97 (3), 497- 501.
10. Miura, T.; Ichiki, H.; Hashimoto, I.; Iwamoto, N.; Kato, M.; Kubo, M.; Ishihara, E.; Komatsu, Y.; Okada, M.; Ishida, T.; Tanigawa, K., Antidiabetic activity of a xanthone compound, mangiferin. Phytomedicine, 2001, 8 (2), 85-87.
11. Sellamuthu, P. S.; Muniappan, B. P.; Perumal, S. M.; Kandasamy, M., Antihyperglycemic Effect of Mangiferin in Streptozotocin Induced Diabetic Rats. J. Health Sci., 2009, 55 (2), 206-214.
12. Niu, Y. C.; Li, S. T.; Na, L. X.; Feng, R. N.; Liu, L. Y.; Li, Y.; Sun, C. H., Mangiferin Decreases Plasma Free Fatty Acids through Promoting Its Catabolism in Liver by Activation of AMPK. Plos One, 2012, 7 (1).
13. Guo, F. C.; Huang, C. H.; Liao, X. L.; Wang, Y. M.; He, Y.; Feng, R. N.; Li, Y.; Sun, C. H., Beneficial effects of mangiferin on hyperlipidemia in high-fat-fed hamsters. Mol. Nutr. Food Res., 2011, 55 (12), 1809-1818.
14. Lim, J.; Liu, Z.; Apontes, P.; Feng, D.; Pessin, J. E.; Sauve, A. A.; Angeletti, R. H.; Chi, Y., Dual mode action of mangiferin in mouse liver under high fat diet. PloS one, 2014, 9 (3), e90137.
15. Apontes, P.; Liu, Z.; Su, K.; Benard, O.; Youn, D. Y.; Li, X.; Li, W.; Mirza, R. H.; Bastie, C. C.; Jelicks, L. A.; Pessin, J. E.; Muzumdar, R. H.; Sauve, A. A.; Chi, Y., Mangiferin stimulates carbohydrate oxidation and protects against metabolic disorders induced by high-fat diets. Diabetes, 2014, 63 (11), 3626-36.
16. Flegal, K. M.; Carroll, M. D.; Ogden, C. L.; Curtin, L. R., Prevalence and Trends in Obesity Among US Adults, 1999-2008. Jama-J. Am. Med. Assoc., 2010, 303 (3), 235-241.
17. Danaei, G.; Finucane, M. M.; Lu, Y.; Singh, G. M.; Cowan, M. J.; Paciorek, C. J.; Lin, J. K.; Farzadfar, F.; Khang, Y. H.; Stevens, G. A.; Rao, M.; Ali, M. K.; Riley, L. M.; Robinson, C. A.; Ezzati, M.; C, G. B. M. R. F., National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2.7 million participants. Lancet, 2011, 378 (9785), 31-40.
18. Rajendran, P.; Rengarajan, T.; Nandakumar, N.; Divya, H.; Nishigaki, I., Mangiferin in cancer chemoprevention and treatment: pharmacokinetics and molecular targets. J. Recep. Signal Transd. Res., 2014, 1-9.
19. Sanchez, G. M.; Re, L.; Giuliani, A.; Nunez-Selles, A. J.; Davison, G. P.; Leon-Fernandez, O. S., Protective effects of Mangifera indica L. extract, mangiferin and selected antioxidants against TPA-induced biomolecules oxidation and peritoneal macrophage activation in mice. Pharmacol. Res., 2000, 42 (6), 565-573.
20. Ghosal, S.; Singh, A. K.; Chaudhuri, R. K., Chemical constituents of genianaceae XX: natural occurrence of (-)-loliolide in Canscora decussata. J. pharmaceut. sci., 1976, 65 (10), 1549-51.
21. Barreto, J. C.; Trevisan, M. T.; Hull, W. E.; Erben, G.; de Brito, E. S.; Pfundstein, B.; Wurtele, G.; Spiegelhalder, B.; Owen, R. W., Characterization and quantitation of polyphenolic compounds in bark, kernel, leaves, and peel of mango (Mangifera indica L.). J. Agri. Food Chem., 2008, 56 (14), 5599-610.
22. Sethiya, N. K.; Trivedi, A.; Patel, M. B.; Mishra, S. H., Comparative pharmacognostical investigation on four ethanobotanicals traditionally used as Shankhpushpi in India. J. Adv. Pharmaceut. Tech. Res., 2010, 1 (4), 388-95.
23. Singh, S. K.; Kumar, Y.; Kumar, S. S.; Sharma, V. K.; Dua, K.; Samad, A., Antimicrobial Evaluation of Mangiferin Analogues. Ind. J. Pharm. Sci., 2009, 71 (3), 328-U106.
24. Muruganandan, S.; Gupta, S.; Kataria, M.; Lal, J.; Gupta, P. K., Mangiferin protects the streptozotocin-induced oxidative damage to cardiac and renal tissues in rats. Toxicology, 2002, 176 (3), 165-73.
25. Luo, F.; Lv, Q.; Zhao, Y.; Hu, G.; Huang, G.; Zhang, J.; Sun, C.; Li, X.; Chen, K., Quantification and Purification of Mangiferin from Chinese Mango (Mangifera indica L.) Cultivars and Its Protective Effect on Human Umbilical Vein Endothelial Cells under H(2)O(2)-induced Stress. Intl. J. Mol. Sci., 2012, 13 (9), 11260-74.
26. Ghosal, S.; Rao, G.; Saravanan, V.; Misra, N.; Rana, D., A plausible chemical mechanism of the bioactivities of mangiferin. Indian J. Chem. B. 1996, 35 (6), 561-566.
27. Jyotshna; Srivastava, P.; Killadi, B.; Shanker, K., Unidimensional double development HPTLC-densitometry method for simultaneous analysis of mangiferin and lupeol content in mango (Mangifera indica) pulp and peel during storage. Food Chem., 2015, 176, 91-8.
28. Sethiya, N. K.; Raja, M. K.; Mishra, S. H., Antioxidant markers based TLC-DPPH differentiation on four commercialized botanical sources of Shankhpushpi (A Medhya Rasayana): A preliminary assessment. J. Adv. Pharmaceut. Tech. Res., 2013, 4 (1), 25-30.
29. Faizi, S.; Zikr-Ur-Rehman, S.; Ali, M.; Naz, A., Temperature and solvent dependent NMR studies on mangiferin and complete NMR spectral assignments of its acyl and methyl derivatives. Magnetic Resonance in Chemistry: MRC, 2006, 44 (9), 838-44.
30. da Cruz, J. W.; de Moraes, L. R.; dos Santos, M. H.; da Silva, G. A.; Brigagao, M. R. P. L.; Ellena, J.; Doriguetto, A. C., Crystalline structure of mangiferin, a C-glycosyl-substituted 9H-xanthen-9-one isolated from the stem bark of Mangifera indica. Helv. Chim. Acta, 2008, 91 (1), 144-154.
31. Bhatia, V. K.; Seshadri, T. R., Synthesis of mangiferin. Tetrahed. lett., 1968, 14, 1741-2.
32. Oyama, K.; Kondo, T., Total synthesis of flavocommelin, a component of the blue supramolecular pigment from Commelina communis, on the basis of direct 6-C-glycosylation of flavan. J. Org. Chem., 2004, 69 (16), 5240-6.
33. Jaramillo, C.; Knapp, S., Synthesis of C-Aryl Glycosides. Synthesis-Stuttgart, 1994, (1), 1-20.
34. Wu, Z.; Wei, G.; Lian, G.; Yu, B., Synthesis of mangiferin, isomangiferin, and homomangiferin. J. Org. Chem., 2010, 75 (16), 5725-8.
35. Bhattacharya, S. K.; Sanyal, A. K.; Ghosal, S., Monoamine oxidase-inhibiting activity of mangiferin isolated from Canscora decussata. Die Naturwissenschaften, 1972, 59 (12), 651.
36. Jangra, A.; Lukhi, M. M.; Sulakhiya, K.; Baruah, C. C.; Lahkar, M., Protective effect of mangiferin against lipopolysaccharide-induced depressive and anxiety-like behaviour in mice. Eur. J. pharmacol., 2014, 740, 337-45.
37. Sethiya, N. K.; Nahata, A.; Dixit, V. K.; Mishra, S. H., Cognition boosting effect of Canscora decussata (a South Indian Shankhpushpi). Eur. J. Integr. Med., 2012, 4 (1), E113-E121.
38. Sethiya, N. K.; Nahata, A.; Mishra, S. H.; Dixit, V. K., An update on Shankhpushpi, a cognition-boosting Ayurvedic medicine. Zhong xi yi jie he xue bao = J. Chinese Integrat. Med., 2009, 7 (11), 1001-22.
39. Andreu, G. L. P.; Maurmann, N.; Reolon, G. K.; de Farias, C. B.; Schwartsmann, G.; Delgado, R.; Roesler, R., Mangiferin, a naturally occurring glucoxilxanthone improves long-term object recognition memory in rats. Eur. J. Pharmacol., 2010, 635 (1-3), 124-128.
40. Bhatia, H. S.; Candelario-Jalil, E.; de Oliveira, A. C.; Olajide, O. A.; Martinez-Sanchez, G.; Fiebich, B. L., Mangiferin inhibits cyclooxygenase-2 expression and prostaglandin E2 production in activated rat microglial cells. Arch. Biochem. Biophy., 2008, 477 (2), 253-8.
41. Han, D.; Chen, C.; Zhang, C.; Zhang, Y.; Tang, X., Determination of mangiferin in rat plasma by liquid-liquid extraction with UPLC-MS/MS. J. Pharmaceut. Biomed. Analysis, 2010, 51 (1), 260-3.
42. Hou, Y. L.; Fan, S. J.; Zhang, H.; Gu, Y. Q.; Yu, X. H.; Li, B. X., Pharmacokinetic study of mangiferin in rat plasma and retina using high-performance liquid chromatography. Mol. Vis., 2010, 16 (178-79), 1659-1668.
43. Liu, Y. M.; Xu, F. P.; Zeng, X.; Yang, L.; Deng, Y. H.; Wu, Z. F.; Feng, Y.; Li, X. O., Application of a liquid chromatography/ tandem mass spectrometry method to pharmacokinetic study of mangiferin in rats. J. Chromatogr. B., 2010, 878 (32), 3345-3350.
44. Liu, H.; Wu, B.; Pan, G.; He, L.; Li, Z.; Fan, M.; Jian, L.; Chen, M.; Wang, K.; Huang, C., Metabolism and pharmacokinetics of mangiferin in conventional rats, pseudo-germ-free rats, and streptozotocin-induced diabetic rats. Drug Metabolism and Disposition: the Biological Fate of Chemicals, 2012, 40 (11), 2109- 18.
45. Ma, H.; Chen, H.; Sun, L.; Tong, L.; Zhang, T., Improving permeability and oral absorption of mangiferin by phospholipid complexation. Fitoterapia. 2014, 93, 54-61.
46. Zhang, H.; Hou, Y. L.; Liu, Y.; Yu, X. H.; Li, B. X.; Cui, H., Determination of Mangiferin in Rat Eyes and Pharmacokinetic Study in Plasma After Oral Administration of Mangiferin-Hydroxypropyl-Beta- Cyclodextrin Inclusion. J. Ocul. Pharmacol. Th., 2010, 26 (4), 319- 324.
47. Liu, H. H.; Wang, K.; Tang, Y. H.; Sun, Z. L.; Jian, L. H.; Li, Z. X.; Wu, B.; Huang, C. G., Structure elucidation of in vivo and in vitro metabolites of mangiferin. J. Pharmaceut. Biomed. Analysis, 2011, 55 (5), 1075-1082.
48. Kammalla, A. K.; Ramasamy, M. K.; Inampudi, J.; Dubey, G. P.; Agrawal, A.; Kaliappan, I., Comparative Pharmacokinetic Study of Mangiferin After Oral Administration of Pure Mangiferin and US Patented Polyherbal Formulation to Rats. AAPS Pharm. Sci. Tech., 2014.
49. Martinez Sanchez, G.; Candelario-Jalil, E.; Giuliani, A.; Leon, O. S.; Sam, S.; Delgado, R.; Nunez Selles, A. J., "Mangifera indica L. extract (QF808) reduces ischaemia-induced neuronal loss and oxidative damage in the gerbil brain". Free Rad. Res., 2001, 35 (5), 465-73.
50. Hou, S. Y.; Wang, F.; Li, Y. M.; Li, Y.; Wang, M. Q.; Sun, D. J.; Sun, C. H., Pharmacokinetic study of mangiferin in human plasma after oral administration. Food Chem., 2012, 132 (1), 289-294.
51. Sanugul, K.; Akao, T.; Li, Y.; Kakiuchi, N.; Nakamura, N.; Hattori, M., Isolation of a human intestinal bacterium that transforms mangiferin to norathyriol and inducibility of the enzyme that cleaves a C-glucosyl bond. Biol. Pharm. Bull, 2005, 28 (9), 1672-1678.
52. Liu, H. H.; Wu, B.; Pan, G. Y.; He, L.; Li, Z. X.; Fan, M. S.; Jian, L. H.; Chen, M. C.; Wang, K.; Huang, C. G., Metabolism and Pharmacokinetics of Mangiferin in Conventional Rats, Pseudo- Germ-Free Rats, and Streptozotocin-Induced Diabetic Rats. Drug Metabol. Disposit., 2012, 40 (11), 2109-2118.
53. Kim, Y.; Lounds-Singleton, A. J.; Talcott, S. T., Antioxidant phytochemical and quality changes associated with hot water immersion treatment of mangoes (Mangifera indica L.). Food Chem., 2009, 115 (3), 989-993.
54. Kim, Y.; Brecht, J. K.; Talcott, S. T., Antioxidant phytochemical and fruit quality changes in mango (Mangifera indica L.) following hot water immersion and controlled atmosphere storage. Food Chem., 2007, 105 (4), 1327- 1334.
55. DiMauro, S.; Schon, E. A., Mechanisms of disease: Mitochondrial respiratory-chain diseases. New Engl. J. Med., 2003, 348 (26), 2656-2668.
56. Lowell, B.B.; Shulmanz, G.I., Mitochondrial dysfunction and type 2 diabetes. Science, 2005, 307 (5708), 384- 387.
57. Wallace, D. C., A mitochondrial paradigm of metabolic and degenerative diseases, aging, and cancer: A dawn for evolutionary medicine. Annu. Rev. Genet., 2005, 39, 359-407.
58. Prabhu, S.; Jainu, M.; Sabitha, K. E.; Shyamala Devi, C. S., Effect of mangiferin on mitochondrial energy production in experimentally induced myocardial infarcted rats. Vasc. Pharmacol., 2006, 44 (6), 519-25.
59. Murphy, M. P., How mitochondria produce reactive oxygen species. Biochem. J., 2009, 417, 1-13.
60. Balaban, R. S.; Nemoto, S.; Finkel, T., Mitochondria, oxidants, and aging. Cell, 2005, 120 (4), 483-495.
61. Chance, B.; Sies, H.; Boveris, A., Hydroperoxide metabolism in mammalian organs. Physiological. Rev., 1979, 59 (3), 527-605.
62. Maritim, A. C.; Sanders, R. A.; Watkins, J. B., 3rd, Diabetes, oxidative stress, and antioxidants: a review. J. Biochem. Mol. Toxicol., 2003, 17 (1), 24-38.
63. Ceriello, A., Oxidative stress and glycemic regulation. Metabolism: clinical and experimental, 2000, 49 (2 Suppl 1), 27-9.
64. Baynes, J. W.; Thorpe, S. R., Role of oxidative stress in diabetic complications: a new perspective on an old paradigm. Diabetes, 1999, 48 (1), 1-9.
65. Drummond, G. R.; Selemidis, S.; Griendling, K. K.; Sobey, C. G., Combating oxidative stress in vascular disease: NADPH oxidases as therapeutic targets. Nat. Rev. Drug. Discov., 2011, 10 (6), 453-471.
66. Wattanapitayakul, S. K.; Bauer, J. A., Oxidative pathways in cardiovascular disease - Roles, mechanisms, and therapeutic implications. Pharmacol. Therapeut., 2001, 89 (2), 187-206.
67. Masibo, M.; He, Q., Major mango polyphenols and their potential significance to human health. Compr. Rev. Food Sci. F., 2008, 7 (4), 309-319.
68. Rajendran, P.; Ekambaram, G.; Sakthisekaran, D., Cytoprotective effect of mangiferin on benzo(a)pyrene-induced lung carcinogenesis in Swiss albino mice. Basic clin. pharmacol. toxicol., 2008, 103 (2), 137-142.
69. Naik, E.; Dixit, V. M., Mitochondrial reactive oxygen species drive proinflammatory cytokine production. J. Exp. Med., 2011, 208 (3), 417-420.
70. Morais, T. C.; Arruda, B. R.; de Sousa Magalhaes, H.; Trevisan, M. T.; de Araujo Viana, D.; Rao, V. S.; Santos, F. A., Mangiferin ameliorates the intestinal inflammatory response and the impaired gastrointestinal motility in mouse model of postoperative ileus. Naunyn-Schmiedeberg's Arch. Pharmacol., 2015, 388(5), 531-538.
71. Garrido, G.; Gonzalez, D.; Lemus, Y.; Delporte, C.; Delgado, R., Protective effects of a standard extract of Mangifera indica L. (VIMANG) against mouse ear edemas and its inhibition of eicosanoid production in J774 murine macrophages. Phytomedicine, 2006, 13 (6), 412-8.
72. Levy, B. D.; Clish, C. B.; Schmidt, B.; Gronert, K.; Serhan, C. N., Lipid mediator class switching during acute inflammation: signals in resolution. Nat. Immunol., 2001, 2 (7), 612-619.
73. Tilley, S. L.; Coffman, T. M.; Koller, B. H., Mixed messages: modulation of inflammation and immune responses by prostaglandins and thromboxanes. J. Clin. Inv., 2001, 108 (1), 15- 23.
74. Serhan, C. N.; Jain, A.; Marleau, S.; Clish, C.; Kantarci, A.; Behbehani, B.; Colgan, S. P.; Stahl, G. L.; Merched, A.; Petasis, N. A.; Chan, L.; Van Dyke, T. E., Reduced inflammation and tissue damage in transgenic rabbits overexpressing 15-lipoxygenase and endogenous anti-inflammatory lipid mediators. J. Immunol., 2003, 171 (12), 6856-6865.
75. Calder, P. C., Polyunsaturated fatty acids and inflammatory processes: New twists in an old tale. Biochimie, 2009, 91 (6), 791-795.
76. Carvalho, R. R.; Pellizzon, C. H.; Justulin, L., Jr.; Felisbino, S. L.; Vilegas, W.; Bruni, F.; Lopes-Ferreira, M.; Hiruma-Lima, C. A., Effect of mangiferin on the development of periodontal disease: involvement of lipoxin A4, anti-chemotaxic action in leukocyte rolling. Chemico-biological Interactions, 2009, 179 (2-3), 344-50.
77. Duang, X. Y.; Wang, Q.; Zhou, X. D.; Huang, D. M., Mangiferin: a possible strategy for periodontal disease to therapy. Med. hypotheses, 2011, 76 (4), 486-8.
78. Hotamisligil, G. S., Inflammation and metabolic disorders. Nature, 2006, 444 (7121), 860-867.
79. Garcia, D.; Leiro, J.; Delgado, R.; Sanmartin, M. L.; Ubeira, F. M., Mangifera indica L. extract (Vimang) and mangiferin modulate mouse humoral immune responses. Phytother. Res., PTR 2003, 17 (10), 1182-7.
80. Muruganandan, S.; Lal, J.; Gupta, P. K., Immunotherapeutic effects of mangiferin mediated by the inhibition of oxidative stress to activated lymphocytes, neutrophils and macrophages. Toxicology, 2005, 215 (1-2), 57-68.
81. Guha, S.; Ghosal, S.; Chattopadhyay, U., Antitumor, immunomodulatory and anti-HIV effect of mangiferin, a naturally occurring glucosylxanthone. Chemotherapy, 1996, 42 (6), 443-51.
82. Xing, X.; Li, D.; Chen, D.; Zhou, L.; Chonan, R.; Yamahara, J.; Wang, J.; Li, Y., Mangiferin treatment inhibits hepatic expression of acyl-coenzyme A:diacylglycerol acyltransferase-2 in fructosefed spontaneously hypertensive rats: a link to amelioration of fatty liver. Toxicol. Appl. Pharmacol., 2014, 280(2), 207-15.
83. Wakil, S. J.; Stoops, J. K.; Joshi, V. C., Fatty acid synthesis and its regulation. Ann. rev. biochem., 1983, 52, 537-79.
84. Hotamisligil, G. S., Inflammation and metabolic disorders. Nature, 2006, 444 (7121), 860-7.
85. Horton, J. D.; Goldstein, J. L.; Brown, M. S., SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver. J. Clin. Invest., 2002, 109 (9), 1125-31.
86. Horton, J. D.; Shah, N. A.; Warrington, J. A.; Anderson, N. N.; Park, S. W.; Brown, M. S.; Goldstein, J. L., Combined analysis of oligonucleotide microarray data from transgenic and knockout mice identifies direct SREBP target genes. Proc. Nat. Acad. Sci. USA, 2003, 100 (21), 12027-32.
87. Foufelle, F.; Ferre, P., New perspectives in the regulation of hepatic glycolytic and lipogenic genes by insulin and glucose: a role for the transcription factor sterol regulatory element binding protein-1c. Biochem. J., 2002, 366 (Pt 2), 377-91.
88. Li, X. J.; Du, Z. C.; Huang, Y.; Liu, B. M.; Hu, W. J.; Lu, W. J.; Deng, J. G., Synthesis and hypoglycemic activity of esterifiedderivatives of mangiferin. Chin. J. Nat. Med., 2013, 11 (3), 296- 301.
89. Wang, H. L.; Li, C. Y.; Zhang, B.; Liu, Y. D.; Lu, B. M.; Shi, Z.; An, N.; Zhao, L. K.; Zhang, J. J.; Bao, J. K.; Wang, Y., Mangiferin Facilitates Islet Regeneration and beta-Cell Proliferation through Upregulation of Cell Cycle and beta-Cell Regeneration Regulators. Int. J. Mol. Sci., 2014, 15 (5), 9016-9035.
90. Li, Y. H.; Peng, G.; Li, Q.; Wen, S. P.; Huang, T. H. W.; Roufogalis, B. D.; Yamahara, J., Salacia oblonga improves cardiac fibrosis and inhibits postprandial hyperglycemia in obese zucker rats. Life sci., 2004, 75 (14), 1735-1746.
91. Giron, M. D.; Sevillano, N.; Salto, R.; Haidour, A.; Manzano, M.; Jimenez, M. L.; Rueda, R.; Lopez-Pedrosa, J. M., Salacia oblonga extract increases glucose transporter 4-mediated glucose uptake in L6 rat myotubes: Role of mangiferin. Clin. Nut., 2009, 28 (5), 565-574.
92. Im, R.; Mano, H.; Matsuura, T.; Nakatani, S.; Shimizu, J.; Wada, M., Mechanisms of blood glucose-lowering effect of aqueous extract from stems of Kothala himbutu (Salacia reticulata) in the mouse. J. ethnopharmacol., 2009, 121 (2), 34-40.
93. Pal, P. B.; Sinha, K.; Sil, P. C., Mangiferin attenuates diabetic nephropathy by inhibiting oxidative stress mediated signaling cascade, TNFalpha related and mitochondrial dependent apoptotic pathways in streptozotocin-induced diabetic rats. PloS one, 2014, 9 (9), e107220.
94. Mahali, S. K.; Manna, S. K., Beta-D-glucoside protects against advanced glycation end products (AGEs)-mediated diabetic responses by suppressing ERK and inducing PPAR gamma DNA binding. Biochem. pharmacol., 2012, 84 (12), 1681-90.
95. Arozal, W.; Suyatna, F. D.; Juniantito, V.; Rosdiana, D. S.; Amurugam, S.; Aulia, R.; Monayo, E. R.; Siswandi, R., The Effects of Mangiferin (Mangifera indica L) in Doxorubicin-induced Cardiotoxicity in Rats. Drug Res., 2014.
96. Huang, T. H.; Yang, Q.; Harada, M.; Uberai, J.; Radford, J.; Li, G. Q.; Yamahara, J.; Roufogalis, B. D.; Li, Y., Salacia oblonga root improves cardiac lipid metabolism in Zucker diabetic fatty rats: modulation of cardiac PPAR-alpha-mediated transcription of fatty acid metabolic genes. Toxicol. App. Pharmacol., 2006, 210 (1-2), 78-85.
97. Zhou, Y. T.; Grayburn, P.; Karim, A.; Shimabukuro, M.; Higa, M.; Baetens, D.; Orci, L.; Unger, R. H., Lipotoxic heart disease in obese rats: implications for human obesity. Proc. Nat. Acad. Sci. USA., 2000, 97 (4), 1784-9.
98. Finck, B. N.; Lehman, J. J.; Leone, T. C.; Welch, M. J.; Bennett, M. J.; Kovacs, A.; Han, X.; Gross, R. W.; Kozak, R.; Lopaschuk, G. D.; Kelly, D. P., The cardiac phenotype induced by PPARalpha overexpression mimics that caused by diabetes mellitus. J. Clin. Invest., 2002, 109 (1), 121-30.
99. Huang, T. H.; Peng, G.; Li, G. Q.; Yamahara, J.; Roufogalis, B. D.; Li, Y., Salacia oblonga root improves postprandial hyperlipidemia and hepatic steatosis in Zucker diabetic fatty rats: activation of PPAR-alpha. Toxicol. App. Pharmacol., 2006, 210 (3), 225-35.
100. Rajendran, P.; Ekambaram, G.; Sakthisekaran, D., Effect of mangiferin on benzo(a)pyrene induced lung carcinogenesis in experimental Swiss albino mice. Nat. Prod. Res., 2008, 22 (8), 672- 680.
101. Rajendran, P.; Ekambaram, G.; Sakthisekaran, D., Protective role of mangiferin against Benzo(a)pyrene induced lung carcinogenesis in experimental animals. Biol. Pharm. Bull, 2008, 31 (6), 1053-8.
102. Rajendran, P.; Ekambaram, G.; Sakthisekaran, D., Cytoprotective effect of mangiferin on benzo(a)pyrene-induced lung carcinogenesis in swiss albino mice. Basic Clin. Pharmacol. Toxicol., 2008, 103 (2), 137-42.
103. Sarkar, A.; Sreenivasan, Y.; Ramesh, G. T.; Manna, S. K., beta-DGlucoside suppresses tumor necrosis factor-induced activation of nuclear transcription factor kappaB but potentiates apoptosis. J. Biol. Chem., 2004, 279 (32), 33768-81.
104. Li, H.; Huang, J.; Yang, B.; Xiang, T.; Yin, X.; Peng, W.; Cheng, W.; Wan, J.; Luo, F.; Li, H.; Ren, G., Mangiferin exerts antitumor activity in breast cancer cells by regulating matrix metalloproteinases, epithelial to mesenchymal transition, and betacatenin signaling pathway. Toxicol. App. Pharmacol., 2013, 272 (1), 180-90.
105. Percival, S. S.; Talcott, S. T.; Chin, S. T.; Mallak, A. C.; Lounds- Singleton, A.; Pettit-Moore, J., Neoplastic transformation of BALB/3T3 cells and cell cycle of HL-60 cells are inhibited by mango (Mangifera indica L.) juice and mango juice extracts. J. Nutri., 2006, 136 (5), 1300-1304.
106. Garcia-Rivera, D.; Delgado, R.; Bougarne, N.; Haegeman, G.; Berghe, W. V., Gallic acid indanone and mangiferin xanthone are strong determinants of immunosuppressive anti-tumour effects of Mangifera indica L. bark in MDA-MB231 breast cancer cells. Cancer lett., 2011, 305 (1), 21-31.
107. Peng, Z. G.; Luo, J.; Xia, L. H.; Chen, Y.; Song, S. J., [CML cell line K562 cell apoptosis induced by mangiferin]. Zhongguo shi yan xue ye xue za zhi/Zhongguo bing li sheng li xue hui = Journal of experimental hematology/Chinese Association of Pathophysiology, 2004, 12 (5), 590-4.
108. Cheng, P.; Peng, Z. G.; Yang, J.; Song, S. J., [The effect of mangiferin on telomerase activity and apoptosis in leukemic K562 cells]. Zhong yao cai, Zhongyaocai. J. Chinese Med. Mater., 2007, 30 (3), 306-9.
109. Warburg, O., On the origin of cancer cells. Science, 1956, 123 (3191), 309-14.
110. Dar, A.; Faizi, S.; Naqvi, S.; Roome, T.; Zikr-ur-Rehman, S.; Ali, M.; Firdous, S.; Moin, S. T., Analgesic and antioxidant activity of mangiferin and its derivatives: the structure activity relationship. Biol. Pharm. Bull, 2005, 28 (4), 596-600.
111. Elchebly, M.; Payette, P.; Michaliszyn, E.; Cromlish, W.; Collins, S.; Loy, A. L.; Normandin, D.; Cheng, A.; Himms-Hagen, J.; Chan, C. C.; Ramachandran, C.; Gresser, M. J.; Tremblay, M. L.; Kennedy, B. P., Increased insulin sensitivity and obesity resistance in mice lacking the protein tyrosine phosphatase-1B gene. Science, 1999, 283 (5407), 1544-8.
112. Klaman, L. D.; Boss, O.; Peroni, O. D.; Kim, J. K.; Martino, J. L.; Zabolotny, J. M.; Moghal, N.; Lubkin, M.; Kim, Y. B.; Sharpe, A. H.; Stricker- Krongrad, A.; Shulman, G. I.; Neel, B. G.; Kahn, B. B., Increased energy expenditure, decreased adiposity, and tissue-specific insulin sensitivity in protein-tyrosine phosphatase 1B-deficient mice. Mol. Cell Biol., 2000, 20 (15), 5479-89.
113. Hu, H. G.; Wang, M. J.; Zhao, Q. J.; Liao, H. L.; Cai, L. Z.; Song, Y.; Zhang, J.; Yu, S. C.; Chen, W. S.; Liu, C. M.; Wu, Q.Y. Synthesis of mangiferin derivatives as protein tyrosine phosphatase 1B inhibitors. Chem. Nat. Compd., 2007, 43 (6), 663-666.
114. Kant Singh, S.; Sinha, S. K.; Prasad, S. K.; Kumar, R.; Bithu, B. S.; Sadish Kumar, S.; Singh, P., Synthesis and evaluation of novel analogues of mangiferin as potent antipyretic. Asian Pacific J. Trop. Med., 2011, 4 (11), 866-9.
115. Abdel-Mageed, W. M.; Bayoumi, S. A.; Chen, C.; Vavricka, C. J.; Li, L.; Malik, A.; Dai, H.; Song, F.; Wang, L.; Zhang, J.; Gao, G. F.; Lv, Y.; Liu, L.; Liu, X.; Sayed, H. M.; Zhang, L., Benzophenone C-glucosides and gallotannins from mango tree stem bark with broad-spectrum anti-viral activity. Bioorg. Med. Chem., 2014, 22 (7), 2236-43.
116. American Heart Association. International cardiovascular disease statistics. Statistical fact sheet 2009 update. http://americanheart.org/ downloadable/heart/1236204012112INTL.pdf.
117. American Heart Association. Heart and stroke facts: statistical update. 2010 Report. http://www.americanheart.org/ downloadable/ heart/1265665152970DS-3241 %20HeartStroke Update_2010.pdf.
118. Nott, P. E.; Roberts, J. C., Structure of mangiferin. Phytochemistry, 1967, 6 (5), 741-7.
119. Bhatia, V. K.; Ramanathan, J.D.; Seshadri, T.R., Constitution of mangiferin. Tetrahedron, 1967, 23 (3), 1363.
120. Wiechowski, W., Phytochemical and pharmacological investigations on mangiferin. Lotos, 1908, 56, 61.
121. van Scherpenberg, A. L., Ebullioscopic determination of molecular weights in pyridine. Rec. Trav. Chim., 1916, 35, 346-64.
122. Nott, P. E.; Roberts, J. C., Synthesis of mangiferin. Phytochemistry, 1967, 6 (11), 1597-9.
123. Aritomi, M.; Kawasaki, T. A., New Xanthone C-Glucoside, Position Isomer of Mangiferin, from Anemarrhena asphodeloides bunge. Chem. Pharm. Bull, 1970, 18, 2327.
124. Aritomi, M.; Kawasaki, T. A., Mangiferin Monomethyl Ether from Mangifera indica L. Chem. Pharm. Bull, 1970, 18, 2224.
125. Saleh, N. A. M.; El-Ansari, M. A. I., Polyphenolics Of Twenty Local Varieties Of Mangifera Indica Mangiferin, from Anemarrhena asphodeloides BUNGE. Planta Med., 1975, 28, 124.
126. Fujita, M.; Inoue, T., Studies on the Constituents of Iris florentina L. II. C-Glucosides of Xanthones and Flavones from the Leaves. Chem. Pharm. Bull, 1982, 30, 2342.
127. Jain, A. C., Khanna, V. K. and Seshadri, T. R.,Synthesis and study of 2-C- and 4 C-methylxanthones. Tetrahedron, 1969, 25(2), 275- 82.
128. Mirza, R. H., Chi N., and Chi, Y., Therapeutic Potential of the Natural Product Mangiferin in Metabolic Syndrome. J. Nutri. Ther., 2013, 2(2), 74-9.
129. McLendon, A. N., Spivey, J., Woodis, C. B., African Mango (Irvingia gabonensis) Extract for Weight Loss: A Systematic Review. J. Nutri. Therapeut., 2013, 2(1), 53-8.
130. Ahmad, A., Padhye, S. and Sarkar, F. H., Role of Novel Nutraceuticals Garcinol, Plumbagin and Mangiferin in the Prevention and Therapy of Human Malignancies: Mechanisms of Anticancer Activity. Nutraceuticals and Cancer, 2012, 179-99.
131. Chaudhuri, R.K.; Ghosal S., Xanthones of Canscora Decussata Schult. Phytochemistry, 1971, 10, 2425-32.
132. Sethiya N. K.; Patel, M. B.; Mishra, S. H., Phyto-pharmacological Aspects of Canscora decussata Roem & Schult. Phcog. Rev., 2010, 4(7), 49-57.
133. Sethiya, N. K.; Nahata, A.; Dixit. V.K., (2009). Comparative thin layer chromatographic investigations on commercial sources of Shankhpushpi in India. Pharmacog. J., 2009, 1(3), 224-226.
134. Sethiya, N. K.; Nahata, A.; Dixit. V.K., Anxiolytic activity of Canscora decussata in albino rats. J. Complemen. Integrat. Med., 2010, 7(1) Article No. 19.
135. Sethiya, N. K.; Nahata, A.; Dixit. V.K., Simultaneous spectrofluorimetric determination of scopoletin and mangiferin in a methanolic extract of Canscora decussata Schult. Asian J. Trad. Med., 2008, 3(6), 224-9.
136. Sethiya, N. K.; Mishra, S. H., Investigation of mangiferin, as a promising natural polyphenol xanthone on multiple targets of Alzheimer's disease. J. Biologically Active Products from Nature, 2014, 4(2), pp. 111-9.
137. Dineshkumar, B.; Mitra, A.; M Manjunatha, M., Studies on the anti-diabetic and hypolipidemic potentials of mangiferin (Xanthone Glucoside) in streptozotocin-induced Type 1 and Type 2 diabetic model rats. Int. J. Adv. Pharmaceut. Sci., 2010, 1, 75-85.